Combigene Ab Stock Price To Sales
| COMBI Stock | SEK 2.60 0.06 2.26% |
Combigene AB fundamentals help investors to digest information that contributes to Combigene's financial success or failures. It also enables traders to predict the movement of Combigene Stock. The fundamental analysis module provides a way to measure Combigene's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Combigene stock.
Combigene |
Combigene AB Company Price To Sales Analysis
Combigene's Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Current Combigene Price To Sales | 1.62 X |
Most of Combigene's fundamental indicators, such as Price To Sales, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Combigene AB is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
| Competition |
Based on the latest financial disclosure, Combigene AB has a Price To Sales of 1.6178 times. This is 92.44% lower than that of the Healthcare sector and 98.36% lower than that of the Biotechnology industry. The price to sales for all Sweden stocks is 85.83% higher than that of the company.
Combigene Price To Sales Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Combigene's direct or indirect competition against its Price To Sales to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Combigene could also be used in its relative valuation, which is a method of valuing Combigene by comparing valuation metrics of similar companies.Combigene is currently under evaluation in price to sales category among its peers.
Combigene Fundamentals
| Return On Equity | 0.48 | |||
| Return On Asset | 0.21 | |||
| Profit Margin | 0.59 % | |||
| Operating Margin | 0.42 % | |||
| Current Valuation | 125.36 M | |||
| Shares Outstanding | 19.8 M | |||
| Shares Owned By Insiders | 31.29 % | |||
| Shares Owned By Institutions | 1.41 % | |||
| Price To Book | 1.06 X | |||
| Price To Sales | 1.62 X | |||
| Revenue | 84.04 M | |||
| Gross Profit | 36.56 M | |||
| EBITDA | 23.56 M | |||
| Net Income | 20.96 M | |||
| Cash And Equivalents | 34.09 M | |||
| Cash Per Share | 1.72 X | |||
| Current Ratio | 5.44 X | |||
| Book Value Per Share | 8.29 X | |||
| Cash Flow From Operations | 22.11 M | |||
| Earnings Per Share | 3.68 X | |||
| Target Price | 2.1 | |||
| Number Of Employees | 11 | |||
| Beta | 1.32 | |||
| Market Capitalization | 165.53 M | |||
| Total Asset | 166.22 M | |||
| Retained Earnings | (5 M) | |||
| Working Capital | 11 M | |||
| Current Asset | 11 M | |||
| Net Asset | 166.22 M |
About Combigene Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Combigene AB's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Combigene using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Combigene AB based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Combigene Stock Analysis
When running Combigene's price analysis, check to measure Combigene's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Combigene is operating at the current time. Most of Combigene's value examination focuses on studying past and present price action to predict the probability of Combigene's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Combigene's price. Additionally, you may evaluate how the addition of Combigene to your portfolios can decrease your overall portfolio volatility.